StemInov 

StemInov is developing an allogenic cell therapy treatment in the field of inflammatory pathologies

OWNER

Julie HUTIN (See Profile)


Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

France


Patented technology

Unique 3D cell production know how

Innovative therapeutic

Status

Approved

IP Type

PCT

Time

19 years

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

MESENCHYMAL STEM CELLS OBTAINED FROM WHARTON’S JELLY FOR THE TREATMENT OF SEPSIS

Know more of this patent

View more

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 14th of July 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar